Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celsion's Breast Cancer Treatment System to be Featured Today On Boston's WHDH-Channel 7 Healthcast Program.


Health/Medical Editors

COLUMBIA, Md.--(BW HealthWire)--May 19, 2000

Celsion Corporation (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB: CELN) a leader in the development of treatment systems for breast cancer, BPH, and other cancer diseases, announced today that its breast cancer treatment This article or section recently underwent a major revision or rewrite and needs further review. You can help!

The mainstay of breast cancer treatment is surgery when the tumor is localized, with possible adjuvant hormonal therapy (with tamoxifen or an aromatase
 technology will be featured on today's segment of WHDH's Healthcast program at 5 p.m. EST. WHDH is the Boston affiliate of NBC. The program will air in the Boston area on Channel 7.

Celsion's treatment, which uses focused microwaves to ablate (kill) tumors without surgery, using heat alone, is currently being featured nationwide in an independently-produced news segment. This is an unsolicited news item.

The adaptive phased technology upon which the treatment is based was originally developed by Dr. Alan Fenn of the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business,  for use in the "Star Wars" defense initiative. Dr. Fenn will be interviewed during the Healthcast segment.

An additional interview, with Dr. Robert Gardner at the Center for Breast Surgery (a member of Columbia Health Care in Florida) and one of his patients, will also be included. Dr. Gardner discusses the benefits of microwave technology.

About Celsion: Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat technology delivered by patented microwave technology. Celsion has research, license or commercialization agreements with leading institutions such as Duke University Medical Center, Massachusetts Institute of Technology, Harbor UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. , the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States).  at San Francisco, Montefiore Medical Center Montefiore Medical Center, in the Bronx, New York, is the university hospital of the Albert Einstein College of Medicine. The hospital, named after Moses Montefiore, is one of the 50 largest employers in New York State [1]. , Memorial Sloan Kettering Cancer Center in New York and Duke University.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 19, 2000
Words:347
Previous Article:Bank Rhode Island Shareholders Approve Holding Company.
Next Article:Ford Motor Company Fund Gives $3.5 Million to Kettering University -- Largest Corporate Donation in University History.
Topics:



Related Articles
Celsion Reports On March 31, 2000 Quarter Improved Balance Sheet.
Massachusetts Institute of Technology Issues Press Release On Its Breast Cancer Treatment Technology, Exclusively Licensed to Celsion Corporation.
Celsion and Boston Scientific Announce Strategic Alliance; Boston Scientific Gains Distribution Rights to Minimally Invasive BPH Technology.
Celsion Presents Preliminary Breast Cancer Treatment Results at 56th Annual Cancer Symposium, Society of Surgical Oncology.
Celsion Forms Office of Chief Executive; Deasey and Reale Assume Operational Responsibilities; Cheung to Focus on Science.
American Medical Association Assigns CPT Code to Celsion's Breast Cancer Treatment System.
Celsion Acquires Duke University's Breast Cancer Hyperthermia Treatment Technology.
Celsion Corporation to Present Preliminary Results of Its Breast Cancer Study at the 9th International Congress on Hyperthermic Oncology.
Celsion Breast Cancer Technology Featured in Newsweek.
Clinical Activity for Celsion's ThermoDox(R) Reported in Newly Presented Data.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles